A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Cardiac resynchronization therapy - Part 2 - Issues during and after device
Tekijät: Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JWH, Garrigue S, Gorcsan J, Hayes DL, Kass DA, Knuuti J, Leclercq C, Linde C, Mark DB, Monaghan MJ, Nihoyannopoulos P, Schalij MJ, Stellbrink C, Yu CM
Kustantaja: ELSEVIER SCIENCE INC
Julkaisuvuosi: 2005
Journal: Journal of the American College of Cardiology
Tietokannassa oleva lehden nimi: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Lehden akronyymi: J AM COLL CARDIOL
Vuosikerta: 46
Numero: 12
Aloitussivu: 2168
Lopetussivu: 2182
Sivujen määrä: 15
ISSN: 0735-1097
DOI: https://doi.org/10.1016/j.jacc.2005.09.020
Tiivistelmä
Encouraged by the clinical success of cardiac resynchronization therapy (CRT), the implantation rate has increased exponentially, although several limitations and unresolved issues of CRT have been identified. This review concerns issues that are encountered during implantation of CRT devices, including the role of electroanatomical mapping, whether CRT implantation should be accompanied by simultaneous atrioventricular nodal ablation in patients with atrial fibrillation, procedural complications, and when to consider surgical left ventricular lead positioning. Furthermore, (echocardiographic) CRT optimization and assessment of CRT benefits after implantation are highlighted. Also, controversial issues such as the potential value of CRT in patients with mild heart failure or narrow QRS complex are addressed. Finally, open questions concerning when to combine CRT with implantable cardioverter-defibritlator therapy and the cost-effectiveness of CRT are discussed.
Encouraged by the clinical success of cardiac resynchronization therapy (CRT), the implantation rate has increased exponentially, although several limitations and unresolved issues of CRT have been identified. This review concerns issues that are encountered during implantation of CRT devices, including the role of electroanatomical mapping, whether CRT implantation should be accompanied by simultaneous atrioventricular nodal ablation in patients with atrial fibrillation, procedural complications, and when to consider surgical left ventricular lead positioning. Furthermore, (echocardiographic) CRT optimization and assessment of CRT benefits after implantation are highlighted. Also, controversial issues such as the potential value of CRT in patients with mild heart failure or narrow QRS complex are addressed. Finally, open questions concerning when to combine CRT with implantable cardioverter-defibritlator therapy and the cost-effectiveness of CRT are discussed.